PainReform Ltd
PRFX
Company Profile
Business description
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
Contact
65 Yigal Alon Street
Tel Aviv6744316
ISRT: +972 37177051
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
6
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,775.40 | 87.40 | 1.01% |
| CAC 40 | 7,537.57 | 52.09 | -0.69% |
| DAX 40 | 23,269.01 | 81.54 | -0.35% |
| Dow JONES (US) | 42,581.78 | 374.96 | 0.89% |
| FTSE 100 | 8,758.04 | 16.61 | -0.19% |
| HKSE | 24,145.11 | 455.98 | 1.92% |
| NASDAQ | 19,630.97 | 183.56 | 0.94% |
| Nikkei 225 | 38,768.23 | 414.14 | 1.08% |
| NZX 50 Index | 12,479.99 | 52.66 | -0.42% |
| S&P 500 | 6,025.17 | 57.33 | 0.96% |
| S&P/ASX 200 | 8,557.60 | 82.70 | 0.98% |
| SSE Composite Index | 3,415.45 | 33.87 | 1.00% |